
A Phase II Study of Dovitinib in Recurrent and/or Metastatic Adenoid Cystic Carcinoma of the Salivary...
Recurrent Adenoid Cystic Carcinoma of the Salivary GlandsMetastatic Adenoid Cystic Carcinoma of the Salivary Glands2 moreThis is a non-randomized, phase II, open label study of dovitinib in patients with progressive, recurrent and/or metastatic adenoid cystic carcinoma (ACC). The primary purpose of this study is to assess the anti-cancer effects of dovitinib in this population in order to evaluate whether dovitinib is worthy of further study in patients with progressive ACC.

A Study of Vitamin C in the Treatment of Liver Cancer to Determine if it is Safe and Effective
Metastatic Hepatocellular CarcinomaAdvanced Liver CancerThis protocol is a phase I/II, study of ascorbic acid (AA) infusions combined with treatment with sorafenib versus treatment with sorafenib alone in subjects with metastatic hepatocellular carcinoma. The phase I aspect will assess the safety and efficacy of the concurrent treatments and the phase II aspect will utilize CT (computer-tomography) scans to assess overall tumor response rate and evaluate disease progression

Study With TMX-101 in Patients With Carcinoma In Situ (CIS) Bladder Cancer
Carcinoma in SituNon Muscle Invasive Bladder CancerThis is a Phase II pilot study to explore the effect of intravesical TMX-101 in patients with CIS bladder cancer, as assessed by histology and cytology after TMX-101 treatment.

Dalantercept in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary...
Recurrent Fallopian Tube CarcinomaRecurrent Ovarian Carcinoma1 moreThis phase II trial studies the side effects and how well dalantercept works in treating patients with ovarian epithelial, fallopian tube, or primary peritoneal cavity cancer that has returned. Dalantercept may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Dalantercept may also stop the growth of tumor cells by blocking blood flow to the tumor.

Sorafenib Combined With Chemotherapy for Renal Collecting Duct Carcinoma
Renal Cell CarcinomaThe goal of this clinical research study is to learn the effectiveness of sorafenib combined with gemcitabine plus cisplatin in the treatment of patients with locally advanced or metastatic collecting duct carcinoma(CDC) of the kidney. The safety of each treatment will also be studied.

A Study of Atezolizumab (an Engineered Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) as Monotherapy...
Renal Cell CarcinomaThis multicenter, randomized, open-label study will evaluate the efficacy, safety and tolerability of atezolizumab as monotherapy or in combination with bevacizumab versus sunitinib in participants with histologically confirmed, inoperable, locally advanced or metastatic renal cell carcinoma who have not received prior systemic therapy either in the adjuvant or metastatic setting.

Phase 3 Study of Bavituximab Plus Docetaxel Versus Docetaxel Alone in Patients With Late-stage Non-squamous...
Non-Small-Cell Lung Cancer Stage IIIBNon-Small-Cell Lung Cancer Stage IV6 moreThe primary purpose of this research study is to see whether adding bavituximab (an investigational drug) to the standard chemotherapy drug docetaxel, will improve the results of the treatment for non-small-cell lung cancer.

Phase I Safety Study of Dendritic Cell Vaccine to Treat Patients With Hepatocellular Carcinoma
Hepatocellular CarcinomaThe primary objective of this study is to answer the question "Is it possible to inject the COMBIG-DC vaccine in a hepatic tumor without getting unacceptable side effects"?

Radiation Therapy and Docetaxel in Treating Patients With HPV-Related Oropharyngeal Cancer
Human Papillomavirus InfectionStage I Oropharyngeal Squamous Cell Carcinoma4 moreThis phase II trial studies how well radiation therapy and docetaxel work in treating patients with human papillomavirus (HPV)-related oropharyngeal cancer. Radiation therapy uses high-energy x-rays to kill tumor cells. Drugs used in chemotherapy, such as docetaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving radiation therapy with docetaxel my kill more tumor cells.

A Study of Pembrolizumab (MK-3475) in Combination With Chemotherapy or Immunotherapy in Participants...
Non-small Cell Lung CarcinomaThe purpose of this study is to determine the safety, tolerability, and efficacy of pembrolizumab (MK-3475) in combination with chemotherapy or immunotherapy in participants with unresectable or metastatic non-small cell lung cancer (NSCLC).